chronic kidney disease, Dr Shuyao Zhang
New diabetes drugs could reduce kidney disease death risk
These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits, slow kidney disease progression, and lower the risk of death for patients with both diabetes and kidney disease.
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...
Since kidney disease often progresses without noticeable symptoms in the early stages, its important to stay vigilant and ...
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.
Chronic kidney disease has been linked to yo-yo dieting (also known as body-weight cycling) in the general population, which ...
"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...
Adults with type 1 diabetes who partake in weight cycling and repeatedly lose and regain body weight are more likely to develop diabetic kidney disease, researchers reported in The Journal of ...
Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback